There can’t be any hotter ticket than this, our new immunology featuring the newly discovered chemistry of the supramolecular “vaccine”> prophylaxis*, and the Old Guard will revolt to protect their own interest. But before any recommendations can be made, we have to put forward the ground rules under which the Federal Drug Administration is empowered to operate within the Federal Drug and Cosmetic Act (FDCA) as both encouragement and caution.
The FDCA recommended nox-toxic prophylaxis for the Measles is supramolecular Morbillinum. Supramolecular means its effective operation is “beyond the molecule” in the transitory energetic plasma phase of the pathogen’s immunity trigger, made so by the hydrolytic ion extraction of the pathogenic germ so as to avoid the use of long term complications of permanently embedded molecular germs and adjuvants of the old “dirty” molecular “vaccines.”
Here are the FDA restrictions regarding recommendations for traditional use of Morbillinum and other supramolecular prophylaxis “vaccines” as provided by the Compliance Policy Guides of the FDCA under the guidance of Sen. Royal Copeland, Chief Sponsor of the Act.
CPG Sec. 400.400 Conditions Under Which Homeopathic Drugs May be Marketed
“A product’s compliance with requirements of the HPUS, USP, or NF does not establish that it has been shown by appropriate means to be safe, effective, and not misbranded for its intended use.
“A guide to the use of homeopathic drugs (including potencies, dosing, and other parameters) may be found by referring to the following texts: A Dictionary of Practical Materia Medica by John Henry Clarke, M.D., (3 volumes; Health Science Press) and A Clinical Repertory to the Dictionary of Materia Medica by John Henry Clarke, M.D. (Health Science Press). These references must be reviewed in conjunction with other available literature on these drug substances.”
More can and should be said, and the reader is invited to join in on the discussion to tease out pro and con. More on product compliance can be found at:
Given that the reader understands the provisions of FDA, let it be said that if you must “vaccinate,” use supramolecular prophylaxis only. We also suggest that supramolecular prophylaxis be tested on non human subjects and administered by licensed practitioners trained in its use only, and that a Federal database be maintained tracking the individual use of supramolecular drugs.
Here is the specific page in the FDA recommended supramolecular treatment of Measles
A DICTIONARY OF PRACTICAL
By John Henry CLARKE, M.D.
Morbillin. The nosode of Measles.
Clinical.─Catarrh. Coryza. Cough. Ear, affections of. Eye, affections of. Measles. Skin, affections of.
Characteristics.─The well-known symptoms which characterise an attack of measles may all be taken as guides for its homœopathic use. Its chief use hitherto has been as a prophylactic against infection, and to clear up after effects of an attack. My own use of it has been confined to the 30th and higher, but there is no bar upon lower potencies, and those who prefer them may begin with the 6th. As a prophylactic given to those who are, or may be, exposed to infection, I prescribe a dose of the 30th twice or thrice daily. For an attack of the disease I find nothing better than Morbil. 30, eight or ten globules in six ounces of water, a dessertspoonful every two hours.─The effect of this is heightened by giving alternately Bell. 30 in the same way. These two medicines will be sufficient to carry through any uncomplicated case, and in my experience do even better than Pulsatilla. As the measles poison has a great affinity for the mucous passages, the eyes, the ears and the respiratory mucous membranes, Morbil. may be used in such cases like any other homœopathic remedy, when the symptoms correspond.
Relations.─Complementary: Bell. Compare: Puls., Hep., Merc., Sul.
*vaccine, meaning from cattle, is a misnomer for prophylaxis, meaning prevention of infection, insemination or pregnancy